Related Experiment Video
Updated: May 11, 2026
06:10
Encapsulated Cell Technology for the Delivery of Biologics to the Mouse Eye
Published on: March 30, 2020
Therapeutic cell encapsulation: ten steps towards clinical translation
Edorta Santos1, José Luis Pedraz, Rosa María Hernández
1NanoBioCel Group, Laboratory of Pharmaceutics, University of the Basque Country, School of Pharmacy, Vitoria, Spain.
Summary
Cell microencapsulation offers a promising way to protect transplanted cells. Overcoming challenges in biomaterials, cell sources, and biosafety is key for clinical translation.
Area of Science:
- Biotechnology
- Regenerative Medicine
- Biomaterials Science
Background:
- Cell microencapsulation was initially promising for protecting transplanted cells from immune rejection.
- Current enthusiasm has waned due to a lack of significant advancements, necessitating critical evaluation.
Purpose of the Study:
- To critically discuss the challenges hindering the clinical translation of cell microencapsulation.
- To identify areas for innovation to realize the therapeutic potential of this biotechnology.
Main Methods:
- Review and critical analysis of existing literature on cell microencapsulation techniques.
- Discussion of biomaterial advancements, cell source optimization, and biosafety considerations.
Main Results:
- Alginate is a suitable biomaterial, but improvements in cross-linkers and coatings are needed.
- Biofunctionalization and tunable degradation rates can enhance matrix performance.
- Mesenchymal stem cells show potential due to hypoimmunogenicity and immunomodulatory properties.
- Suicide/reporter genes and minimally invasive procedures address biosafety and delivery concerns.
Conclusions:
- Significant challenges remain in biomaterial refinement, cell source selection, and biosafety.
- Addressing cost-effectiveness, scale-up, and regulatory hurdles is crucial for clinical success.
- Further research and development are essential to translate cell microencapsulation into viable clinical therapies.
